Where does Rambam Medtech Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rambam Medtech Ltd. ranks #19,065 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rambam Medtech Ltd. hold?

Rambam Medtech Ltd. holds 15 US utility patents granted between 2016 and 2025, spanning 12 technology areas.

What is Rambam Medtech Ltd.'s Innovation Score?

Rambam Medtech Ltd. has an Innovation Score of 36.9 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rambam Medtech Ltd. focus on?

Rambam Medtech Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents, ranking #2,680 of 7,127 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Rambam Medtech Ltd.'s patent grant rate increasing or decreasing?

Rambam Medtech Ltd.'s recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Rambam Medtech Ltd.'s patents?

Rambam Medtech Ltd.'s patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rambam Medtech Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rambam Medtech Ltd.

USPTO PatentsView assignee record - 15 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rambam ranks #19,065 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 12 technology areas.

#19,065
of 49,997 US assignees by volume: Top 45%
by Innovation Score (36.9/100): 14.0
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19065 · Foreign Corporation #19,065 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,065/49,997
PHOTO-FINISH Quantum Elements…
CPC-FOCUS A61B · 12 areas
INNOV-THIN 36.9/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Quantum Elements Development Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rambam’s 36.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (26%) Velocity 6.7 pts (18%) Breadth 12.2 pts (33%) Claim depth 8.4 pts (23%)

Qualcomm Incorporated · highest

85
Rambam Medtech · this assignee

37
3D Lighting… · lowest

7

What this shows Rambam's Innovation Score is 36.9/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rambam?

Each dot is one of Rambam’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rambam’s own 14.0 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rambam vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rambam's grants concentrate

Rambam Medtech Ltd. is a focused PatentsView assignee: 12 CPC subclasses with 40% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2016. By volume, Rambam sits between Quantum Elements Development Inc. and Realpage, Inc..

Rambam's three-year grant acceleration

Rambam Medtech Ltd. shows 6 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Quantum Elements…

15
Quickthree Techno…

15
R-stor

15
R2 Solutions

15
Rancilio Group S…

15
Rauland-borg

15
Realmfive

15
Realpage

15
Rambam Medtech ◀

15

What this shows Rambam holds 15 patents at rank #19,057, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rambam

By rank, the assignees closest to #19,057 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Rambam's primary technology class.

Rambam's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Rambam Medtech Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.7%
2018	1	6.7%
2019	2	13.3%
2020	1	6.7%
2021	3	20.0%
2022	1	6.7%
2023	3	20.0%
2024	2	13.3%
2025partial year	1	6.7%

Which technologies does Rambam Medtech Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

C12Y - Enzymes 3

C07K - Peptides 3

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rambam Medtech Ltd.'s patent record in context - here's where to go next.

Rambam Medtech Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 40% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #19,065 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rambam Medtech Ltd. against Quantum Elements Development Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.